Rifampin Capsules — Class II drug recall D-0098-2023
Terminated recall by RemedyRepack Inc., reported 2023-01-18. Failed Impurities/Degradation specifications
| Recall number | D-0098-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2022-12-20 |
| Classified | 2023-01-06 |
| Reported by FDA | 2023-01-18 |
| Terminated | 2023-03-03 |
| Reason classes | specification failure |
| NDC | 68180-0659-07, 70518-2404-00 |
| Lot numbers | J0599794-022322, J0621369-052622 |
| Expiration dates | 2023-02-28, 2023-06-30 |
Product
Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.
Reason for recall
Failed Impurities/Degradation specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0098-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.